Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002291 · ClinicalTrials.gov registry record · NA
The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before
A NA study, sponsored by Fisons.
- Completed
- Registry status
- NA
- Development phase
NCT00002291: Completed NA study, sponsored by Fisons.
NCT00002291 is a NA study that has completed, run by Fisons. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002291, a NA study, has completed, sponsored by Fisons.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To evaluate and compare the safety, tolerability, and efficacy of biweekly administration of 1 of 3 doses of aerosol pentamidine when used as a prophylactic agent in patients who have recovered from their first episode of AIDS-associated Pneumocystis carinii pneumonia (PCP).
Interventions
- DRUG Pentamidine isethionate
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002291 record still lists
NCT00002291 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Pentamidine isethionate is the first listed.
NCT00002291 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002291 about?
NCT00002291 is a clinical study titled "The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP Before". To evaluate and compare the safety, tolerability, and efficacy of biweekly administration of 1 of 3 doses of aerosol pentamidine when used as a prophylactic agent in patients who have recovered from their first episode of AIDS-associated Pneumocystis carinii pneumonia (PCP).
What is the current status of trial NCT00002291?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002291?
The interventions under investigation include: Pentamidine isethionate (DRUG).
Who is sponsoring clinical trial NCT00002291?
This trial is sponsored by Fisons, which has 5 total clinical trials registered on ClinicalTrials.gov.